Loading
No insider purchase over the last 90 days. The latest, by Reuter Joseph Anthony, was filed 07 Jun 2023.
Stericycle Inc: what insiders have been doing
Stericycle Inc, founded in 1989, is a Energy company based in Lake Forest, United States. Its directors and officers file their transactions with SEC (Form 4). Stericycle Inc has had no insider filing for more than a year; the last one goes back to 4 November 2024.
Looking back to 2017, when coverage begins, insiders filed 12 purchases and 28 sales.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
387
Thresholds
n/a
Buy Volume
€1M
12 ops. · all time
Sell Volume
€31M
28 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2023FY ended December 2023 · cache
Income statement
RevenueUS$2.3B
Gross profitUS$873.6M38% margin
Net income-US$49.3M-2.2% margin
Last declaration on 4 November 2024
Declarations387 total
10,831 shares@ US$62.00100.0% of flowCommon StockSEC:0001415889-24-026023:0
32,163 shares@ US$62.0086.4% of flowCommon StockSEC:0001415889-24-026015:0
52,310 shares@ US$62.00100.0% of flowCommon StockSEC:0001415889-24-026018:0
41,446 shares@ US$62.0082.9% of flowCommon StockSEC:0001415889-24-026017:0
25,069 shares@ US$62.0094.5% of flowCommon StockSEC:0001415889-24-026019:0
116,954 shares@ US$62.00100.0% of flowCommon StockSEC:0001415889-24-026025:0
24,313 shares@ US$62.00100.0% of flowCommon StockSEC:0001415889-24-026030:0
4,296 shares@ US$62.00100.0% of flowCommon StockSEC:0001415889-24-026029:0
20,747 shares@ US$62.00100.0% of flowCommon StockSEC:0001415889-24-026020:0
16,096 shares@ US$62.00100.0% of flowCommon StockSEC:0001415889-24-026031:0
6,000 shares@ US$62.0055.8% of flowCommon StockSEC:0001415889-24-026014:0
13,435 shares@ US$62.00100.0% of flowCommon StockSEC:0001415889-24-026016:0
20,303 shares@ US$62.00100.0% of flowCommon StockSEC:0001415889-24-026022:0
2,465 shares@ US$62.00100.0% of flowCommon StockSEC:0001415889-24-026024:0
21,345 shares@ US$62.00100.0% of flowCommon StockSEC:0001415889-24-026026:0
33,382 shares@ US$62.00100.0% of flowCommon StockSEC:0001415889-24-026021:0
3,620 shares0Common StockSEC:0001415889-24-013749:0
3,620 shares0Common StockSEC:0001415889-24-013747:0
3,620 shares0Common StockSEC:0001415889-24-013750:0
3,620 shares0Common StockSEC:0001415889-24-013748:0
5,534 shares0Common StockSEC:0001415889-24-008496:0
2,410 shares0Common StockSEC:0001415889-24-008504:0
1,545 shares0Common StockSEC:0001415889-24-008506:0
1,199 shares0Common StockSEC:0001415889-24-008513:0
2,656 shares0Common StockSEC:0001415889-24-008508:0
25 of 387 declarations
About Stericycle Inc
Stericycle Inc. was a U.S.-based business services company focused on regulated waste and compliance solutions, and it was historically listed in the United States on the NASDAQ under ticker SRCL. Founded in 1989, the company built its reputation over more than three decades as a specialist in medical waste management, secure information destruction, and compliance-support services for healthcare and commercial customers. Its headquarters were in Bannockburn, Illinois, in the greater Chicago area, reflecting its long-standing roots in the highly regulated environmental and healthcare-services segment. A key point for investors is that Stericycle is no longer an independent listed company: WM completed its acquisition in late 2024, and SRCL ceased trading on NASDAQ after the deal closed.
Stericycle’s core business centered on the collection, transport, treatment, and disposal of regulated medical waste, a service category that demands strict chain-of-custody controls, specialized processing infrastructure, and continuous adherence to environmental and public-health rules. Beyond medical waste, the company offered secure information destruction services, helping customers dispose of paper and other media containing sensitive or confidential data. It also provided compliance-oriented solutions, including support around HIPAA and OSHA requirements, as well as services related to pharmaceutical and hazardous waste streams in certain customer segments. This integrated model positioned Stericycle as a one-partner solution for hospitals, physician offices, laboratories, dental practices, and commercial organizations that needed both operational reliability and regulatory assurance.
Read moreShow less
From a competitive standpoint, Stericycle’s value proposition rested on scale, recurring service relationships, operational expertise, and the complexity barrier of the markets it served. The company operated in a fragmented industry where trust, compliance credentials, and route density matter materially. That made it relatively well positioned versus smaller local operators, especially for multi-site customers and national healthcare systems. Stericycle’s footprint extended across North America and, according to company disclosures, parts of Europe and other international markets.
Recent developments have been dominated by the WM transaction, which is the most important corporate event in the company’s recent history. Prior to the acquisition, Stericycle had also continued to expand and refresh its operating platform, including investments in medical waste processing capacity and newer product offerings such as improved waste containers. For investors analyzing SRCL-related SEC Form 4 insider transactions, the key takeaway is that the stock’s independent public-market story is now in the past, and the name should be viewed primarily through its legacy operating profile and the final pre-acquisition filings rather than as a currently traded standalone equity.
